Our data confirmed (Figure 4) that DHCT effectively inhibited the effects of α7nAChR and JAK2 in nicotine-treated HCC cells, which subsequently reduced their migration/invasion abilities by disturbing the expression of EMT biomarkers (E-cadherin and vimentin) and a transcription factor (Slug). Here, JAK2 is linked to hepatocellular carcinoma.